Company Filing History:
1 out of 10 
1 out of 5 
1 out of 2 Years Active: 2018-2025
Title: The Innovative Contributions of Inventor Feng-Lin Chiang
Introduction: Feng-Lin Chiang, based in Taipei, Taiwan, is a notable inventor recognized for his advancements in medical technology. With one patent to his name, Chiang has significantly contributed to the field of cancer treatment through innovative antibody-drug conjugates.
Latest Patents: Feng-Lin Chiang holds a patent for his work on anti-folate receptor alpha (FRA) antibody-drug conjugates. This patent involves compositions and methods for utilizing hydrophilic self-immolative linkers in drug delivery, demonstrating potential for enhancing treatment efficacy in cancer therapies.
Career Highlights: Throughout his career, Feng-Lin has worked with various reputable companies specializing in biopharmaceuticals. Notably, he has been associated with BioAlliance, a prominent player in the field of drug development, and Abgenomics International Inc., which focuses on innovative therapeutic solutions.
Collaborations: Feng-Lin Chiang has collaborated with esteemed colleagues, including Rong-Hwa Lin and Shih-Yao Lin, to advance their research and development efforts. Their collective work showcases the importance of teamwork in innovation and enhancing cancer treatment methodologies.
Conclusion: Feng-Lin Chiang's contributions to the medical field, particularly in developing anti-folate receptor alpha antibody-drug conjugates, reflect his commitment to innovation and improving patient outcomes. His work exemplifies the vital role that inventors play in advancing healthcare technologies.